Can Intravenous Ketamine Reduce Risk for Postpartum Depression?
Intravenous ketamine at delivery reduced risk for postpartum depression; however, only in women at high risk for PPD.
Intravenous ketamine at delivery reduced risk for postpartum depression; however, only in women at high risk for PPD.
Many women experience depression during pregnancy. What is the best way to identify these women?
This review suggests that CBT can be used to target depression during pregnancy and can be delivered using a digital platform.
Prenatal exposure to valproic acid was associated with an increased risk of autism spectrum disorder in exposed children.
Few resources are available to support fathers after pregnancy loss.
This article reviews the research on the effects of antenatal maternal psychological states on offspring.
Intranasal oxytocin improves mood in postpartum women but has no impact on mood in women with more severe depressive symptoms.
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on practicing perinatal psychiatry in 2022 with Ob.Gyn News on January 21, 2022. The [...]
Some studies have demonstrated associations between in utero exposure to antidepressants and cognitive outcomes.
Children of mothers with eating disorders, and in particular the children of mothers with a current diagnosis of anorexia nervosa during pregnancy, are at an increased risk of either ADHD or ASD.